// App-Quantinova.ai

1075 : Prognostic utility of tumour infiltrating lymphocytes (TILs) and neutrophil-to-lymphocyte ratio (NLR) in early-stage triple negative breast cancer (TNBC).

Researchers

Presenter

  • Antonia Pearson

Principal Investigators

  • Pickett Justine

  • Connie Irene Diakos

  • Robert Dewar

  • David Chan

  • Alexander David Guminski

  • Anthony J. Gill

  • Alexander M. Menzies

  • Sally E. Baron-Hay

Medical Centers

  • Medical Oncology Department, Royal North Shore Hospital, St Leonards, Australia

  • Anatomical Pathology, Royal North Shore Hospital and Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, Sydney, Australia

  • Sydney Medical School, University of Sydney, St Leonards, Australia

  • Medical Oncology Department, Royal North Shore Hospital, St Leonards, Australia

  • Anatomical Pathology, Royal North Shore Hospital and Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, Sydney, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

Biomarkers

  • Neutrophil lymphocyte ratio

  • Stromal tumor infiltrating lymphocytes

  • tumor-infiltrating lymphocytes

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved